DONATE TODAY
To Increase Patient Access

Meet the Team

Dellann Elliott Mydland

Founder/President
The EndBrainCancer Initiative (formerly, The Chris Elliott Fund), was established in May, 2002 by my late husband, Chris Elliott, and I. The reason for this Initiative, the Chris Elliott Fund, and our day-to-day work has always been about IMMEDIATE ACCESS to advanced treatments, studies and clinical trials and the frustration we experienced early on in our brain cancer journey with not being immediately referred to a top brain tumor specialist, neurosurgeon and/or a neuro-oncologist as well as advanced treatments, studies and clinical trials.
COMPLETE BIO

Board of Directors

DELLANN ELLIOTT MYDLAND

Board Chair & President

HUNTER ELLIOTT

Vice President

SHAWN DRENNAN, MBA

Treasurer

ANNETTE MONKS

Board Member
Board Governance Chair

LISA LENROW, MBA

Secretary

CAROL TILLERY

Board Member
Fundraising Committee Chair

Jolene Anderson

Board Member
Advisory & Scientific Committee

Mission Team

DELLANN ELLIOTT MYDLAND

CEO/Program Director

SHAWN DRENNAN, MBA

Board Member, Treasurer & Head of Finance & Operations

SUSAN KELLNER

Communications
Global Digital Outreach & Education

TODD MOUDY

Head of IT
Nimbusnet

MARY BORROWS

Executive Partner to
President & CEO

CHARLOTTE TOMIC

Public Relations Specialist

MEGAN PATTON

Survivor Ambassador

JENNIE RICHEY

Advancement

ELISE FYHRIE

Disease Education, Awareness & Outreach EBCI Mobile App Manager

STEPHANIE HAIDAR

Communications Manager

TED LYSZCZARZ

Website Support

SHREYA S. PRAKASH

Clinical Research Coordinator/Patient Navigator

MONIQUE SAMODIEN

Program Coordinator/Intern

JASON LOMBARD

OPERATIONAL  STRATEGIST

CAROL TILLERY

Patient Advocate

Jennifer Ortiz

Patient Advocate

SASHA QUIJANO

Pediatric Clinical Trial Coordinator
Patient Navigator
BECOME A VOLUNTEER!

ENDBRAINCANCER INITIATIVE | CHRIS ELLIOTT FUND

Enhancing patient outcomes by expanding FDA-approved treatment modalities and fueling research in the pharma/bio/life sciences, device & diagnostic industries and by closing the existing GAP from initial diagnosis to IMMEDIATE AND EXPANDED ACCESS to specialists, researchers, advanced & innovative treatments, clinical trials and critical care with the ultimate goal of improving patient outcomes through updating and improving WHO & NCCN Guidelines and clinical practices related to Standard of Care for brain cancer patients.

TAX ID:26-2185614
DONATE
corporate partners
upcoming events
resources
About us
envelopephonemap-markerpointer-right
linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram